Ullah A, Chen G, Hussain A, et al. Int J Nanomedicine. 2021;16:4451–4470.
The authors have advised there is an error in the author list on page 4451. The text “Muhammad Usman,6” should read “Muhammad Usman,8”.
The authors apologize for this error.
. 2021 Sep 7;16:6203–6204. doi: 10.2147/IJN.S336782
Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis [Corrigendum]
Received 2021 Aug 30; Accepted 2021 Aug 30; Collection date 2021.
© 2021 Ullah et al.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
PMCID: PMC8434834 PMID: 34522096
This corrects the article "Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis" on page 4451.